Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zoetis Inc.ZTS · Entity 679 | Executive Vice President | March 16, 2022 | March 18, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zoetis Inc.
Report date March 16, 2022 · Filed March 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,218 |
Ending reported balance
After 2022-03-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-16 · Exercise / conversion · Acquired 6,000 · Balance 14,218 Row 2 · 2022-03-16 · Sale · Disposed 6,000 · Balance 8,218 F1: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock OptionSEC Table II · derivative / convertible security | Direct | 33,941 |
Reported balance
After 2022-03-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-16 · Exercise / conversion · Disposed 6,000 · Balance 33,941 F2: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F3: 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option. F4: Each option vests on the third anniversary of the date of grant. F5: Each option expires on the tenth anniversary of the date of grant. F6: 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. |
Filing footnotes · ownership attribution and instrument terms
F1: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F3: 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
F4: Each option vests on the third anniversary of the date of grant.
F5: Each option expires on the tenth anniversary of the date of grant.
F6: 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000118 · wf-form4_164763586368220.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,941 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. F3 · derivative.exercise_price: 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 6,000 | $188.15 | $1,128,900.00 |
DisclosureSEC source: 0001555280-22-000118 · wf-form4_164763586368220.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,218 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 6,000 | $87.51 | $525,060.00 |
DisclosureSEC source: 0001555280-22-000118 · wf-form4_164763586368220.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 12,022.9538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · derivative · entry 6 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,022.9538 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 3,486.86 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · derivative · entry 5 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,334.3508 Underlying: Common Stock · 3,486.86 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,486.8600 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,191.0030 RSUs will vest on February 10, 2024; and 1,862 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,486.8600 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,191.0030 RSUs will vest on February 10, 2024; and 1,862 RSUs will vest on February 8, 2025. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,486.8600 RSUs vested on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,191.0030 RSUs will vest on February 10, 2024; and 1,862 RSUs will vest on February 8, 2025. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 5,651 | $198.87 | $1,123,814.37 |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · nonDerivative · entry 4 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,218 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 12,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · nonDerivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 1,639 | $198.87 | $325,947.93 |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,847 Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-22-000110 · wf-form4_164497315117775.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 7,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,941 Underlying: Common Stock · 7,332 shares Expires not disclosed F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F10 · derivative.exercise_price: 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,821.2108 Underlying: Common Stock · 1,862 shares Expires not disclosed F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F8 · balance_after: The RSUs vest as follows: 3,486.8600 RSUs will vest on February 12, 2022; 2,281.3478 RSUs will vest on February 11, 2023; 2,191.0030 RSUs will vest on February 10, 2024; and 1,862 RSUs will vest on February 8, 2025. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:43 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 12,022.9538 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-22-000068 · wf-form4_164453658234517.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,022.9538 Underlying: Common Stock · 12,022.9538 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 3,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000301 · wf-form4_163337808697447.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,609 Underlying: Common Stock · 3,287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,287 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:08 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,497 | $194.14 | $873,047.58 |
DisclosureSEC source: 0001555280-21-000301 · wf-form4_163337808697447.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,287 | $73.24 | $240,739.88 |
DisclosureSEC source: 0001555280-21-000301 · wf-form4_163337808697447.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,896 Underlying: Common Stock · 3,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 3,287 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,492 | $187.00 | $840,004.00 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,210 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,285 | $73.24 | $240,593.40 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 20:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000211 · wf-form4_161886258555129.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,181 Underlying: Common Stock · 3,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 6,572 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 20:03 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,491 | $165.00 | $741,015.00 |
DisclosureSEC source: 0001555280-21-000211 · wf-form4_161886258555129.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,417 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 20:03 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,285 | $73.24 | $240,593.40 |
DisclosureSEC source: 0001555280-21-000211 · wf-form4_161886258555129.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,466 Underlying: Common Stock · 3,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,857 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 4,491 | $165.82 | $744,697.62 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,623 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,285 | $73.24 | $240,593.40 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 5,409.6632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · derivative · entry 6 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,409.6632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 3,705.5275 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · derivative · entry 5 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,915.6078 Underlying: Common Stock · 3,705.5275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,705.5275 RSUs vested on February 13, 2021; 3,467.7579 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,179 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,705.5275 RSUs vested on February 13, 2021; 3,467.7579 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,179 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,705.5275 RSUs vested on February 13, 2021; 3,467.7579 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,179 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 2,543 | $166.71 | $423,943.53 |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · nonDerivative · entry 4 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,829 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 5,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · nonDerivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 1,742 | $166.71 | $290,408.82 |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 23:00 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 3,705 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000138 · wf-form4_161360279169654.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:21 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 9,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000093 · wf-form4_161317207712772.xml · derivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,751 Underlying: Common Stock · 9,254 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 23:21 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 2,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000093 · wf-form4_161317207712772.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,621.1353 Underlying: Common Stock · 2,179 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,705.5275 RSUs will vest on February 13, 2021; 3,467.7579 RSUs will vest on February 12, 2022; 2,268.8499 RSUs will vest on February 11, 2023; and 2,179 RSUs will vest on February 10, 2024. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:13 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 5,409.6632 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000042 · wf-form4_161308518363274.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,409.6632 Underlying: Common Stock · 5,409.6632 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 4,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000284 · wf-form4_160167649956010.xml · derivative · entry 5 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,497 Underlying: Common Stock · 4,080 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F6 · derivative.exercise_price: 4,080 options granted February 14, 2017 at an exercise price of $55.02 per option. F7 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F8 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 3,639 | $166.25 | $604,983.75 |
DisclosureSEC source: 0001555280-20-000284 · wf-form4_160167649956010.xml · nonDerivative · entry 4 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.01 to $166.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 1,530 | $165.76 | $253,612.80 |
DisclosureSEC source: 0001555280-20-000284 · wf-form4_160167649956010.xml · nonDerivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,639 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.02 to $165.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 332 | $164.93 | $54,756.76 |
DisclosureSEC source: 0001555280-20-000284 · wf-form4_160167649956010.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,169 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.60 to $164.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 4,080 | $55.02 | $224,481.60 |
DisclosureSEC source: 0001555280-20-000284 · wf-form4_160167649956010.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 4,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,577 Underlying: Common Stock · 4,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 4,080 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 5,499 | $137.29 | $754,957.71 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,421 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 4,079 | $55.02 | $224,426.58 |
DisclosureSEC source: 0001555280-20-000226 · wf-form4_159372832141968.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| April 07, 2020 Filed Apr 7, 2020 20:24 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 4,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,656 Underlying: Common Stock · 4,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 8,159 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| April 07, 2020 Filed Apr 7, 2020 20:24 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 5,499 | $130.00 | $714,870.00 |
DisclosureSEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,841 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| April 07, 2020 Filed Apr 7, 2020 20:24 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 4,079 | $55.02 | $224,426.58 |
DisclosureSEC source: 0001555280-20-000170 · wf-form4_158629108231547.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 4,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000130 · wf-form4_158223399588780.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,735 Underlying: Common Stock · 4,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 4,079 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 12,238 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; and 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 5,499 | $143.42 | $788,666.58 |
DisclosureSEC source: 0001555280-20-000130 · wf-form4_158223399588780.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,261 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.81 to $143.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 4,079 | $55.02 | $224,426.58 |
DisclosureSEC source: 0001555280-20-000130 · wf-form4_158223399588780.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 6,402.4514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000114 · wf-form4_158215009286508.xml · derivative · entry 6 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,402.4514 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 4,321.2978 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000114 · wf-form4_158215009286508.xml · derivative · entry 5 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,388.6588 Underlying: Common Stock · 4,321.2978 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,321.2978 RSUs vested on February 14, 2020; 3,684.5409 RSUs will vest on February 13, 2021; 3,448.1179 RSUs will vest on February 12, 2022; and 2,256 RSUs will vest on February 11, 2023. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,321.2978 RSUs vested on February 14, 2020; 3,684.5409 RSUs will vest on February 13, 2021; 3,448.1179 RSUs will vest on February 12, 2022; and 2,256 RSUs will vest on February 11, 2023. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,321.2978 RSUs vested on February 14, 2020; 3,684.5409 RSUs will vest on February 13, 2021; 3,448.1179 RSUs will vest on February 12, 2022; and 2,256 RSUs will vest on February 11, 2023. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:08 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 3,010 | $144.17 | $433,951.70 |
DisclosureSEC source: 0001555280-20-000114 · wf-form4_158215009286508.xml · nonDerivative · entry 4 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,681 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.